A Portable Thoracic Impedance Device for Detecting Pulmonary Congestion in Heart Failure Patients
Condition(s) studied
Investigational drug(s) / intervention(s)
Thoracic bioimpedance tomography: Data collection using a thoracic bioimpedance tomography device
Study summary
This study investigates a portable thoracic bioimpedance tomography (TBIT) device designed to detect early lung congestion in heart failure patients. The main goal is to evaluate how well the device's measurements match those obtained from lung ultrasound and other imaging techniques. By detecting lung fluid build-up before symptoms worsen, this device could help manage heart failure more effectively outside of hospital settings, potentially improving patient care and reducing hospital admissions. Participants in the study are monitored using this device along with standard imaging methods, and data on heart failure symptoms are collected to understand the device\'s accuracy and usability.
Eligibility
Primary outcome measure(s)
- Lung congestion — Baseline, week 4, week 8
Assessed using lung ultrasound over 12 thoracic zones to calculate the B-line score
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CHUM | Montreal | Quebec | Recruiting |
More Centre hospitalier de l'Université de Montréal (CHUM) trials in Canada
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06604468 on ClinicalTrials.gov ↗ ← All trials in Canada